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Abstract
Background: Androgens are known to delay lung development. As a consequence, the incidence and morbidity of
respiratory distress syndrome of the neonate are higher for male than for female premature infants. We previously
reported that many genes were expressed with a sex difference in the mouse developing lung and that several
genes were under the control of androgens in the male fetal lung. microRNAs are small non-coding RNAs known
to negatively regulate the expression of specific genes. In this study, we examined whether murine miRNAs are
under the control of androgens in the male developing lung.
Methods: Expression profiling of microRNAs was performed by microarrays using RNA extracted from male fetal
lungs isolated on gestational day (GD) 17.0 and GD 18.0 after daily injection of pregnant mice from GD 10.0 with
the antiandrogen flutamide or vehicle only. To identify putative miRNA target genes, the data obtained here were
combined with gene profiling data reported previously using the same RNA preparations. qPCR was used to
confirm microarray data with fetal lungs from other litters than those used in microarrays.
Results: Flutamide induced downregulation and upregulation of several miRNAs on GD 17.0 and GD 18.0. Of the
43 mature miRNAs modulated by flutamide on GD 17.0, 60 % were downregulated, whereas this proportion was
only of 34 % for the 35 mature miRNAs modulated on GD 18.0. For 29 and 26 flutamide-responsive miRNAs, we
found a corresponding target inversely regulated by androgens on GD 17.0 and 18.0, respectively. The androgen-
regulated target genes were involved in several biological processes (lipid metabolism, cell proliferation, and lung
development) and molecular functions, mainly transcription factor binding.
Conclusions: Regulation of male lung development involves several miRNAs that are under androgen modulation
in vivo.
Keywords: microRNA, Androgens, Preterm birth, Sex differences, Respiratory distress syndrome, Lung development,
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Background
Respiratory distress syndrome (RDS) is one of the most
common complications of preterm babies [1]. The major
cause of this disease is surfactant deficiency [2, 3], which
is related to the immaturity of type II pneumonocytes
(PTII), the surfactant-producing and -secreting cells [4].
Clinically, RDS is characterized by a sexual dimorphism
with preterm boys more affected than preterm girls [5, 6].
This would be explained by a sexual difference in the
timing of PTII cell maturation and the surge of surfactant
synthesis leading to a disadvantage for male neonates
[7–9]. Indeed, treatments in vitro and in vivo with the
androgen dihydrotestosterone (DHT) or the antiandro-
gen flutamide demonstrated that androgens are respon-
sible for the delay in PTII cell maturation and in the
surge of surfactant synthesis in males [10, 11]. Add-
itionally, experiments with testicular feminization mice
(Tfm) showed that these negative actions of androgens
occur via the androgen receptor (AR) [12] which is
expressed in both male and female fetal lungs [13].
We previously reported that the expression profile of
many genes presented a sexual dimorphism in the fetal
lung at the end of the pseudoglandular [14], during the
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canalicular [14, 15], and at the beginning of the saccular
stage of lung development [15]. Furthermore, we dem-
onstrated that several genes were actively modulated by
androgens in vivo on gestation days (GDs) 17.0 and 18.0
[15], a period including the surge of surfactant synthesis
and the transition from the canalicular to the saccular
stage. Since androgens have an important impact on the
timing of lung maturation, it is important to deepen our
knowledge on the regulatory mechanisms involved
downstream of the activation of the androgen receptor.
miRNAs are small non-coding RNAs known to
negatively regulate the expression of specific gene(s)
by degrading mRNA(s) or inhibiting its/their transla-
tion into protein [16]. miRNAs are highly conserved
across species [17]. They are involved in several
physiological processes such as cell differentiation,
proliferation, apoptosis, and lipid metabolism [18–21].
The importance of miRNAs in lung development was
first demonstrated by Harris et al., who reported abnormal
growth of epithelial tube, and an arrest of branching were
observed in conditional knockout mice of Dicer, an im-
portant ribonuclease involved in biogenesis of mature
miRNAs [22]. It was also demonstrated on GD 11.5 that
two members of the Argonaute protein family, AGO1 and
AGO2, were specifically expressed in lung distal epithe-
lium and mesenchymal cells, respectively [23]. Therefore,
these two RNA-induced silencing complex (RISC)
components must be involved in cell-specific gene
regulation. Finally, it was showed that miRNAs were
dynamically regulated across lung development from
the pseudoglandular to the alveolar stage [24].
Several miRNAs display a sexual dimorphism in their
expression levels in different species [25–27]. Regulation
of miRNA levels by sex steroids such as estradiol, pro-
gesterone, and testosterone has also been demonstrated
[28–30]. A previous study reported sex differences in
miRNA levels in the developing lung between GD 15.0
and GD 18.0 [31]. However, no study has examined sex
steroid modulation of miRNA levels in fetal lungs. In
the present study, using the antiandrogen flutamide, we
investigated for the first time whether androgens
modulate miRNAs expression in fetal murine lung




Protocols were approved by the Comité de Protection des
Animaux du CHU de Québec (protocol no. 2011-053). Fe-
male and male Balb/c mice (Charles River Laboratories,
Saint-Constant, QC, Canada) were housed with a 12-h
light/dark cycle. Tap water and feed were provided ad libi-
tum. Animals were mated in a 1-h mating window as pre-
viously described [15]. Pregnant females received a daily
subcutaneous injection of 1 mg of the antiandrogen fluta-
mide (kindly provided by Dr. Fernand Labrie) in 200 μl ve-
hicle (0.9 % NaCl, 1 % gelatin (w/v) (ACP Chemicals,
Saint-Léonard, QC, Canada), 10 % dimethylsulfoxide
(Sigma-Aldrich, St. Louis, MO)) or vehicle only from GD
10.0 to the day prior to sacrifice. Pregnant females were
sacrificed on GD 17.0 or GD 18.0 (term is GD 19.0) by ex-
posure to CO2. GD 17.0 corresponded exactly to 17 days
0 h after the end of the 1-h mating window. From each
fetus, the lungs and a rear leg were harvested, rapidly fro-
zen on dry ice, and then stored at −80 °C until use.
Fetal sex determination
Fetal sex was confirmed by PCR amplification of the
male-specific Sry gene (GenBank: X67204) from fetal
legs. DNAs were extracted with Extracta DNA Prep for
PCR-Tissue (Quanta BioSciences). PCR reactions were
performed using AccuStart PCR SuperMix Kit (Quanta
BioSciences) according to the protocol of the manufac-
turer with 0.04 nM of each Sry primer (forward 5′-
TATGGTGTGGTCCCGTGGTG-3′; reverse 5′-ATGT-
GATGGCATGTGGGTTCC-3′), resulting in a 282-
nucleotide amplicon. The following PCR conditions were
used: 94 °C for 5 min and 72 °C for 10 min followed by
34 cycles of 94 °C for 1 min, 65 °C for 1 min, and 72 °C
for 1 min. Final extension was done at 72 °C for 10 min.
Agarose gel electrophoresis was used for amplicon
visualization.
RNA extraction and sampling
Total RNA was extracted from the fetal lung of male sub-
jects using TRI Reagent, a mixture of phenol and guan-
idine thiocyanate in a monophasic solution (Molecular
Research Center, Cincinnati, OH, USA) and purified on a
CsCl gradient as previously described [13]. The quality of
RNA for microarray experiments was monitored by
micro-capillary electrophoresis (Bioanalyzer 2100, Agilent
Technologies, Santa Clara, CA, USA). For qPCR experi-
ments, the RNA integrity was verified by gel electrophor-
esis. For all the experiments, RNA purity was determined
using a Nanodrop 1000 spectrophotometer (Thermo
Scientific). For all the samples, the OD 260/280 ratio
was above 1.8. For microarray experiments, biological
duplicates (n = 2 RNA pools) were prepared for each
experimental condition with RNA from 4 to 5 male
fetuses for each pool.
Microarray experiments
Total RNA including low molecular weight RNA was
labeled using the Flashtag RNA labeling kit (Affymetrix,
Santa Clara, CA, USA) according to the manufacturer’s
instructions. Briefly, for each sample, 400 ng of total
RNA was subjected to a tailing reaction followed by the
ligation of the biotinylated signal molecule to the target
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RNA sample. Each sample was hybridized to a GeneChip®
miRNA Array 3.0 (Affymetrix, Santa Clara, CA, USA) for
16 h at 48 °C at 60 rpm. After washing and staining with a
Fluidics Station 450 (Fluidics script FS450_0002), arrays
were scanned with a GeneChip® Scanner 3000 7G
(Affymetrix). The image data were analyzed with the
Expression Console Software (www.affymetrix.com) for
quality control. GeneChip® miRNA Array 3.0 contained
19,724 total mature miRNA probe sets and covered 153
organisms. This array contained 1111 and 855 mouse ma-
ture miRNA and pre-miRNA, respectively. miRNA probes
of this array were derived from the Sanger miRBase
miRNA database v17.
Microarray data analysis
CEL files were imported and analyzed with the Partek
Genomics Suite 6.6 software (Partek Incorporated,
St. Louis, MO, USA). Background correction and
normalization of probe set intensities were performed
using the Robust Multiarray Analysis (RMA) method [32].
Quantile normalization was achieved and intensity values
were Log2 transformed. Groups were compared by
ANOVA analysis, and p values were corrected using the
false discovery rate (FDR) procedure. The differences were
considered statistically significant when p < 0.05 and
FDR < 5 %. miRNAs were combined with their corre-
sponding targets belonging to the GEO (GSE18135)
data sets by Partek software based on the TargetScan-
Mouse v6.2 algorithm. A chi-square test (2 × 2 table)
was performed to analyze the significance of the variation
in the proportions of miRNAs regulated by flutamide be-
tween GD 17.0 and GD 18.0.
Reverse transcription and quantitative PCR
Reverse transcription and qPCR of miRNAs and
normalization genes were performed as previously de-
scribed [33]. Briefly, 200 ng of each RNA sample was de-
natured and mixed with 62.5 μM of each dNTP and
50 nM of the stem-loop primer at 65 °C for 5 min and
then transferred on ice. First-strand buffer (SuperScript
II kit, Life Technologies), 4 units of Protector RNase In-
hibitor (Promega), and 50 units of SuperScript II RT
(Life Technologies) were added to the mixture for a total
reaction volume of 20 μl. Samples were incubated for
30 min at 16 °C, followed by pulsed reverse transcription
of 60 cycles at 30 °C for 30 s, 42 °C for 30 s, and 50 °C
for 1 s. Reverse transcriptase was then inactivated at
85 °C for 5 min. qPCR was performed using the FastStart
Essential DNA Green qPCR Master Mix kits and a LC96
Instrument (Roche Diagnostics). Reactions were per-
formed according to the manufacturer’s instructions with
0.5 μM of each primer and 20 ng of total RNA input in a
final volume of 20 μl. Samples were incubated at 95 °C for
5 min, followed by 43 cycles of 95 °C for 5 s and 60 °C for
10 s. At the end of each run, samples were heated to 95 °C
with a temperature transition rate of 0.2 °C/s to construct
dissociation curves. The stability of five normalization
genes was assessed by geNorm software as previously de-
scribed [34]. The best combination of reference genes was
used for relative quantification of microRNAs. The list of
reverse transcription and qPCR primers for miRNAs and
normalization genes are presented in Additional file 1:
Table S1. The groups were compared using unpaired Stu-
dent’s t test. The differences were considered statistically
significant when p < 0.05.
Results
Androgen-regulated miRNA expression
Pregnant females were subjected to the antiandrogen
flutamide or vehicle administration from GD 10.0 to the
day prior sacrifice on GD 17.0 or 18.0. For each experi-
mental condition, two biological replicates were studied.
Each replicate contained lung RNA from several individ-
ual male fetuses belonging to different litters. Expression
profiling of androgen-regulated miRNA was assessed by
microarrays. For each gestation time, expression data
from flutamide-treated males was compared with data
from males injected with vehicle. Androgen-regulated
miRNA were detected on GD 17.0 and GD 18.0 (Fig. 1a).
Only two miRNAs overlapped the two gestational ages.
The expression profile of differentially expressed miR-
NAs is presented for each replica (Fig. 1b). Of the 43
mature miRNAs modulated by flutamide on GD 17.0,
60 % were downregulated, whereas this proportion was
only of 34 % for the 35 mature miRNAs modulated on
GD 18.0 (Fig. 1c). This difference was statistically signifi-
cant (chi-square 5.29, p = 0.021).
qPCR analysis of microarray data
After obtaining microarray data, animal breeding was
reinitiated to produce independent RNA/cDNA samples
to validate microarray data by qPCR. In contrast to RNA
samples for microarrays, RNAs for qPCR were pooled
by litter (one pool of male fetal lung RNA/litter). Three
RNA pools were obtained for vehicle treatment for each
age, while five pools were used for flutamide treatment
for each age. Five reference genes were tested by geN-
orm: sno202, sno234, sno251, sno135, and sno142. Two
were selected for normalization: sno202 and sno235
(Fig. 2a). Eleven miRNAs were randomly selected for
qPCR analysis for each age: GD 17.0 miR-1843-5p, miR-
485-3p, miR-711, miR-3962, miR-3067-3p, miR-212-3p,
miR-669i, miR-877, miR-26b-3p, miR-465c-3p, let-7b-3p;
GD 18.0 miR-1843-5p, miR-485-3p, miR-3473d, miR-
132-5p, miR-3074-1-3p, miR-128-2-5p, miR-130b-5p,
miR-490-5p, miR-669h-3p, miR-3058-5p, miR-146b. A
statistically significant effect of flutamide was observed
for seven of these miRNAs (miR-26b-3p, let-7b-3p, miR-
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465c-3p, miR-669h-3p, miR-3058-5p, miR-146b, miR-
1843-5p), and a trend toward a statistically significant ef-
fect was observed for another miRNA (miR-130b-5p)
(Fig. 2b, c). A statistically significant effect of flutamide
was observed for miR-1843-5p on GD 18.0 but not on
GD 17.0. For the other miRNAs, variations in expression
levels from litter to litter prevented obtaining statistically
significant differences (data not shown). The seven miR-
NAs presenting a statistically significant effect of fluta-
mide and miR-130b-5p were used to compare qPCR and
microarray data. All of them showed a similar effect of
flutamide by qPCR and microarrays (Fig. 2d). According
to the miRNA quality control (miRQC) study reported
in 2014 [35], microarrays and qPCR approaches pre-
sented a concordance rate lower than 70 % for quantifi-
cation of miRNA expression.
Functional analysis of androgen-modulated miRNA
For microarrays, we utilized the RNA preparations that
were used in our previous publication studying expres-
sion profiling of androgen-modulated genes [15]. Thus,
the present miRNA profiling data were combined with
the mRNA profiling data in order to pair miRNA with
their potential targets showing an opposite regulation by
flutamide. In silico miRNA-mRNA combination was
performed. For 29 and 26 of the flutamide-responsive
mature miRNAs, we found a corresponding target in-
versely regulated by androgens on GDs 17.0 and 18.0,
respectively. Among all these mRNA targets, 25 were
common to GD 17.0 and GD 18.0. Gene Ontology (GO)
analysis was performed to determine biological processes
(Fig. 3) and molecular functions (Fig. 4) involving
androgen-regulated miRNAs and their corresponding
targets. Among the biological processes, lipid metabol-
ism, cell proliferation, lung development, Wnt signaling
pathway, and angiogenesis showed the highest number
of genes targeted by miRNAs for the two gestational
ages (Fig. 3; Tables 1 and 2). For the molecular func-
tions, transcription factor binding was the group with
the highest number of targeted genes (Fig. 4) on GD
17.0 (Table 3) and GD 18.0 (Table 4).
The following miRNAs, shown to be involved in lung
development, were not modulated by flutamide in our
experiment: miR-221 [36], miR-429/200a/200b/200c/141
from the miR-200 family [37], miR-150 [38], miR-142
[39], miR-127 [40], miR-375 [41], and miR-26a [42].
Discussion
The importance of miRNAs in lung development has
been reported in several studies [43]. Knowing that an-
drogens modulate lung development [9, 44], we investi-
gated the possibility that several androgen effects be
mediated by the regulation of miRNAs. We demonstrate
for the first time in this report that the levels of several
miRNAs are modulated by androgens in late developing
lungs on GDs 17.0 and 18.0. These two gestational days
overlap the transition period from the canalicular to the
saccular stages. The canalicular stage is characterized by
the formation of distal airway bronchioles, epithelial
Fig. 1 Overview of the microarray data obtained from fetal mouse
lungs exposed or not to flutamide. a Number of androgen-regulated
miRNAs on GD 17.0 and GD 18.0. b Expression profile of differentially
expressed miRNAs is presented for each replica and each gestation
time. Red and blue indicate the intensity level above and below the
median, respectively, for each miRNA and each replicate. For each
age, results are given for the two replicates (1, 2) for male exposed
to vehicle (mv), and male exposed to flutamide (mf). c Number of
androgen-modulated mature miRNA according to their reactivity to
flutamide at GD 17.0 and GD 18.0
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differentiation into type I and type II pneumonocytes,
and the beginning of angiogenesis. The saccular stage in-
cludes the formation of terminal saccules, epithelial cell
thinning, and growth of capillary networks. Between
GDs 17.0 and 18.0, important changes in lung morpho-
genesis occur, which are accompanied by variations in
the expression of several genes. These dynamic changes
are compatible with our data showing a different profile
of androgen-modulated miRNAs for each age, with only
two miRNAs in common between the two gestational
days. In fact, 76 miRNAs were modulated by androgens.
Of these, 41 and 33 were specifically modulated on GD
17.0 and GD 18.0, respectively.
We previously demonstrated that 1597 and 1775 genes
were modulated by flutamide on GD 17.0 and GD 18.0,
respectively, in the fetal mouse lung [15]. Of these, only
590 and 428 genes, respectively, presented a sex difference
[15]. Based on the demonstration that steroidogenic
Fig. 2 Validation of microarray data by qPCR for several miRNAs. a Selection of reference genes by geNorm among the five tested candidates.
The average of expression stability M is presented for each tested reference gene candidate (left panel). The two most stable genes yielded the
lower pairwise variation value (0.179) (right panel). Quantification of several miRNAs by qPCR on GD 17.0 (b) and GD 18.0 (c). d Comparison of
expression ratios (flutamide/vehicle) obtained by microarray and qPCR for seven miRNA genes
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enzymes involved in the synthesis and inactivation of an-
drogens are expressed in the developing lung of both
sexes, a role for androgens was proposed in lung develop-
ment of females as well as males [13, 45, 46]. This does
not exclude sex differences originating most probably
from circulating androgens of testicular origin. Levels of
androgen-regulated miRNAs are dependent on androgen
receptor activation, which is affected by the availability of
androgens, which in turn is affected by circulating
amounts of androgens and by local expression of steroido-
genic enzymes. One androgen-synthesizing enzyme,
17β-hydroxysteroid dehydrogenase (HSD) type 5 (GenBank
accession no. AH007907), and one androgen-inactivating
enzyme, 17β-HSD type 2 (NM_008290), are both expressed
in the mouse developing lung at levels that were
shown to vary according to developmental time and
from litter to litter [13]. As a consequence, the ampli-
tude of the effect of androgens on miRNA expression
is likely to vary from litter to litter. Therefore, sam-
pling may induce variations in the levels of androgen-
regulated miRNAs. qPCR experiments were designed
not only to study the effect of flutamide but also to
evaluate the reproducibility from litter to litter. Our
data indicate that the effect of flutamide observed
from the population cannot always be observed for
individual litters.
The design of our study did not allow identification of
target genes of miRNAs acting through the inhibition of
translation but rather of those targeting mRNA stability.
The particular interest of our miRNA profiling experi-
ment is that we used the same RNA samples as those
used for gene profiling of the effect of flutamide by
Bresson et al. [15]. Therefore, we combined the data from
the two profiling studies to select miRNA-regulated target
genes showing an opposite modulation by flutamide com-
pared to their corresponding miRNAs. Flutamide inhibits
Fig. 3 Number of androgen-regulated miRNAs and their potential androgen-regulated targets according to biological processes on GD 17.0 (a)
and GD 18.0 (b)
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specifically the androgen receptor response. Positive and
negative effects of androgens are inhibited by flutamide,
leading to an apparent downregulation or upregulation of
gene expression, respectively. Since each gene may be sub-
jected to several miRNAs and other regulatory factors, the
putative target genes of a given miRNA are not all ex-
pected to be inversely regulated compared to this miRNA.
Nevertheless, our approach identified combinations of
miRNAs and their mRNA targets that were inversely
modulated by flutamide. The combination of the two pro-
filing studies revealed that the target genes inversely regu-
lated by flutamide compared to miRNAs were involved in
several biological processes and molecular functions rele-
vant to lung development such as lipid metabolism, cell
proliferation and differentiation, cell-cell signaling, several
signaling pathways, angiogenesis, and more as presented
in Figs. 3 and 4.
Two miRNAs among the 20 most abundant miRNAs
detected in the fetal lung on GD 17.5 [47] were down-
regulated by androgens (upregulated by flutamide) on
GD 17.0 in our study, namely, miR-92a-1-5p and miR-
449a. miR-92a-1-5p belongs to the miR-17/92 cluster in-
volved in lung morphogenesis and overexpressed in the
early stage of lung development [47]. Accordingly, mice
deficient for miR17/92 die shortly after birth with lung
hypoplasia and cardiac defects [48]. Transducin (beta)-
like 1X-related protein 1 (TBL1XR1 or TBLR1) mRNA
is a predictive target for miR-449a that is conversely reg-
ulated by androgens. The corresponding protein is in-
volved in β-catenin binding since it is essential for the
recruitment of β-catenin for Wnt-β-catenin-mediated
transcription [49]. Then, downregulation of miR-449a by
androgens and, consequently, upregulation of TBL1XR1
should positively regulate Wnt-β-catenin gene expres-
sion on GD 17.0.
miR-449a is also known to target jagged 1 (jag1)
mRNA, which encodes the ligand of the Notch 1 recep-
tor. It was previously demonstrated that the miR-449
family contributes to cell fate determination by targeting
the Notch signaling pathway [50]. Our results showed
that jag1 mRNA is also regulated by two other miRNAs
(miR-126-5p and let-7b-3p) that, like miR-449a, were
upregulated by flutamide. Moreover, two other genes
also involved in the Notch signaling pathway, ADAM10
and ADAM17, were upregulated by androgens like jag1,
and their miRNAs were upregulated by flutamide
(Table 1). These data strongly suggests that the Notch
signaling pathway should be under androgen regulation
on GD 17.0. Notch proteins and their ligands are highly
expressed in lung development [51, 52] since they are
required for the differentiation of epithelial cells, more
specifically ciliated cells, in the bronchial epithelium.
Our data strongly suggest that these effects of Notch sig-
naling may be regulated positively by androgens.
It was reported that the Let-7 family, including let-7f-
2-3p and let-7b-3p, are the most abundant miRNAs in
the fetal lung on GD 17.5 [47]. It was shown that fetal
lung expression levels of mmu-let-7b-3p were lower in
early than in late developmental stages [40]. Two mem-
bers of the Let-7 family, let-7f-2-3p and let-7b-3p, were
Fig. 4 Number of androgen-regulated miRNAs and their potential androgen-regulated targets according to molecular functions on GD 17.0 (a)
and GD 18.0 (b)
Bouhaddioui et al. Biology of Sex Differences  (2016) 7:20 Page 7 of 13
downregulated by androgens in the present study. In
addition to jag1 mRNA mentioned above, the messenger
of transducin-like enhancer of split 4 (Tle4) is also a let-
7b-3p putative target gene downregulated by flutamide.
Tle4 is known to be expressed in embryonic stem cells
where it acts as a repressor of cell pluripotency and self-
renewal, thus favoring cell differentiation [53]. Given
that the Tle4 mRNA was downregulated by flutamide in
our experiments, androgens may exert a positive pres-
sure in the favor of cell differentiation through let-7b-3p.
Table 1 Androgen-regulated miRNAs and their corresponding
mRNA target(s) on GD 17.0 classified according to several
biological processes
Biological process Gestational day 17.0
miRNA mRNA target














Cell proliferation mmu-miR-1306-5p Zeb2
mmu-miR-1955-5p Gng2
mmu-miR-215 Igf1; Zeb2
















Cell-cell signaling mmu-miR-3078 Gabra1; Gja1
mmu-miR-1306-5p Gja1
mmu-let-7f-2-3p Gabra1










Table 1 Androgen-regulated miRNAs and their corresponding








































Italicized data are upregulated by flutamide; boldface data are downregulated
by flutamide
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Our data showed that several androgen-modulated
genes involved in growth factor signaling [15] are tar-
geted by androgen-modulated miRNAs. Among these,
insulin-like growth factor 1 gene (IGF1) was under posi-
tive regulation by androgens through miR-215 on GD
17.0, and through miR-30e, miR-1251, miR-709, miR-
344f-3p, and miR-466l-5p on GD 18.0. IGF1 is involved
in cell proliferation and distal epithelium differentiation
in prenatal lung [54]. Interestingly, IGF1 expression was
upregulated in RDS [55], which presented a higher inci-
dence and morbidity for males, whereas we show in this
report that IGF1 mRNA levels were upregulated by an-
drogens. Moreover, IGF2 mRNA levels were also posi-
tively modulated by androgens. It is a putative target of
miR-215, which in turn is negatively regulated by
Table 2 Androgen-regulated miRNAs and their corresponding
mRNA target(s) on GD 18.0 classified according to several
biological processes
Biological process Gestational day 18.0
miRNA mRNA target












































Table 2 Androgen-regulated miRNAs and their corresponding
mRNA target(s) on GD 18.0 classified according to several
biological processes (Continued)






























Italicized data are upregulated by flutamide; boldface data are downregulated
by flutamide
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androgens. As demonstrated by the study of IGF2−/−
mice, a lack of IGF2 leads to a delay in lung maturation
characterized by a dense pseudoglandular-like appear-
ance on GD 17.5 [56].
Nuclear receptor 2 factor 2 (Nr2f2), also known as
chicken ovalbumin upstream promoter-transcription fac-
tor II (COUP-TFII), antagonizes retinoic acid (RA) sig-
naling in the developing lung, allowing the formation of
distal lung structures under the regulation of FGF10 and
BMP4 [57]. Our data showed that COUP-TFII mRNA
levels were downregulated by androgens on GD 17.0 but
not on GD 18.0 [15]. In this report, some miRNAs
Table 4 Androgen-regulated miRNAs and their corresponding
mRNA target(s) on GD 18.0 classified according to several
molecular functions
Molecular function Gestational day 18.0
miRNA mRNA target





Phospholipid binding mmu-miR-130a Ccdc88a
mmu-miR-30e Eea1; Nr5a2






Beta-catenin binding mmu-miR-669h-3p Apc
mmu-miR-669h-3p Cd2ap
SMAD binding mmu-miR-30e Zeb2
mmu-miR-130a Zeb2
mmu-miR-666-5p Zeb2
Transcription factor binding mmu-miR-202-5p Bcl2; Creb1
mmu-miR-30e Bcl2
mmu-miR-703 Bcl2; Med13; Creb1










Italicized data are upregulated by flutamide; boldface data are downregulated
by flutamide
Table 3 Androgen-regulated miRNAs and their corresponding
mRNA target(s) on GD 17.0 classified according to molecular
functions
Molecular function Gestational day 17.0
miRNA mRNA target
Steroid binding mmu-miR-126-5p Igf1
mmu-miR-215 Igf1





SMAD binding mmu-miR-1306-5p Zeb2
mmu-miR-215 Zeb2














Beta-catenin binding mmu-miR-687 Apc
mmu-miR-449a Tbl1xr1
mmu-let-7f-2-3p Cd2ap



















Italicized data are upregulated by flutamide; boldface data are downregulated
by flutamide
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putatively targeting the COUP-TFII mRNA were con-
versely regulated by androgens on GD 17.0: miR-291a-
3p, miR-467b and miR-467d, and miR467h. Therefore,
these miRNAs must participate in the negative regula-
tory pressure of androgens on the expression of COUP-
TFII and thus cause a delay in the formation of distal
lung structures.
miR-130a was shown to be expressed in murine fetal
lung, where a decrease in miR-130a levels was observed
from GD 15.0 to GD 17.0, followed by an increase up to
GD 18.0 [36]. It was observed that pulmonary localization
of this miRNA changed according to gestational age and
corresponded on GD 18.0 to terminal bronchioles and
mesenchymal cells around developing saccules [36]. Up-
regulation of miR-130a was shown to increase vascular
density and distal airway branching [36]. In contrast,
downregulation of miR-130a with an anti-miR led to re-
duced airway branching in the lung explant [36]. Our data
indicated that miR-130a levels were upregulated by fluta-
mide on GD 18.0. One putative miR-130a target is cAMP
response element binding protein 1 (Creb1) mRNA. Creb1
is also regulated by flutamide and plays an important role
in the differentiation of epithelial cells, mainly type I epi-
thelial cells [58]. Our data suggest that androgens exert
both a positive pressure on the expression of Creb1 and a
negative pressure on vascularization and distal airway
branching on GD 18.0 through miR-130a. Another puta-
tive target of miR-130a is Zeb2 mRNA. This messenger
was downregulated by flutamide on GD 18.0 in our previ-
ous gene profiling study [15]. Zeb2 repressed transcription
of E-cadherin and, consequently, epithelial cell polarity
and adhesion [59]. Zeb2 was also shown to be involved
in type II epithelial cell differentiation [37]. Therefore,
upregulation of Zeb2 by androgens may impact these
mechanisms.
Some miRNAs modulated by flutamide in our study
have also been shown to be regulated by hyperoxia, which
is a model of bronchopulmonary dysplasia [60, 61]. Let-
7f-2-3p (GD 17.0), miR-30e (GD 18.0), and miR-709 (GD
18.0) were upregulated by flutamide in our experiment,
whereas they were upregulated by hyperoxia during the
postnatal period [60, 61]. In contrast, miR-146b was up-
regulated by flutamide but downregulated by hyperoxia
[61]. Knowing that a sex difference was reported in the in-
cidence of bronchopulmonary dysplasia (BPD) [62–64]
and that this sex difference may originate from androgens,
it would be interesting to test whether the miRNAs regu-
lated by androgens at ages cited above are involved in the
sex difference observed in BPD.
Conclusions
The levels of several miRNAs are modulated by andro-
gens in the developing lung on GDs 17.0 and 18.0 thus
during the transition from the canalicular to the saccular
stage. Comparison with data from our previous study
on the effect of the antiandrogen flutamide on the
genomics of the developing lung allowed pairing of several
androgen-regulated miRNAs with their androgen-regulated
putative target(s). Putative miRNA target genes belonged to
several biological processes and functions important for
lung development.
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